|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Dalteparin#Adult Indications and Dosage]] |
| {{Dalteparin}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Indications and Usage==
| |
| ===Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave Myocardial Infarction===
| |
| | |
| FRAGMIN® Injection is indicated for the prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction, when concurrently administered with [[aspirin]] therapy [see Clinical Studies (14.1)].
| |
| | |
| ===Prophylaxis of Deep Vein Thrombosis===
| |
| | |
| FRAGMIN is also indicated for the prophylaxis of deep vein thrombosis ([[DVT]]), which may lead to pulmonary embolism ([[PE]]):
| |
| | |
| In patients undergoing hip replacement surgery [see Clinical Studies (14.2)];
| |
| In patients undergoing abdominal surgery who are at risk for thromboembolic complications [see Clinical Studies (14.3)];
| |
| In medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness [see Clinical Studies (14.4)].
| |
| | |
| ===Extended Treatment of Symptomatic Venous Thromboembolism in Patients with Cancer===
| |
| | |
| FRAGMIN is also indicated for the extended treatment of symptomatic [[venous thromboembolism]] ([[VTE]]) (proximal [[DVT]] and/or [[PE]]), to reduce the recurrence of [[[VTE]] in patients with cancer In these patients, the FRAGMIN therapy begins with the initial [[VTE]] treatment and continues for six months [see Clinical Studies (14.5)].
| |
| | |
| '''''Limitations of Use '''''
| |
| Fragmin is not indicated for the acute treatment of [[VTE]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FRAGMIN (DALTEPARIN SODIUM) INJECTION [EISAI INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5cd4a8e-14c0-440b-b453-9f3d3250c951 | publisher = | date = | accessdate = 31 January 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Heprin group]]
| |
| [[Category:Anticoagulants]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |